CIK 0001478320
- Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 270907024
- Phone
- +1 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- 4 Planned sale Chief Scientific Officer sold 1,698 shares at $9.00 ($15,282)
- 4 Exercise or conversion Chief Financial Officer acquired 2,500 shares (option exercise)
- 4 Open-market sale Director sold 36,291 shares at $7.19 ($260,932)
- 4 Open-market sale Director sold 53,000 shares at $7.59 ($402,270)
- 4 Open-market sale Director sold 10,000 shares at $7.05 ($70,500)
- 4 Open-market sale Chief People Officer sold 20,875 shares at an average $6.99 ($145,845)
- 4 Open-market sale Chief Commercial Officer, MRD sold 26,023 shares at $6.98 ($181,641)
- 4 Open-market sale Chief Commercial Ofc Imm Med sold 44,665 shares at an average $6.98 ($311,792)
- 4 Open-market sale Chief Financial Officer sold 10,320 shares at an average $6.98 ($72,072)
- 4 Open-market sale President and COO sold 59,505 shares at an average $6.98 ($415,540)
- 4 Open-market sale Chief Scientific Officer sold 96,656 shares at an average $6.99 ($675,219)
- 4 Open-market sale CEO and Chairman sold 219,569 shares at an average $7.29 ($1,600,417)
- 4 Grant or award Director acquired 15,394 shares (grant or award)
- 4 Grant or award Director acquired 15,394 shares (grant or award)
- 4 Grant or award Director acquired 15,394 shares (grant or award)
- 4 Grant or award Director acquired 15,394 shares (grant or award)
- 4 Planned sale Director sold 15,664 shares at $7.94 ($124,372)
- 4 Planned sale CEO and Chairman sold 285,187 shares at an average $8.45 ($2,410,700)
- 4 Planned sale CEO and Chairman sold 470,368 shares at an average $8.47 ($3,985,754)
- 4 Open-market sale Chief Financial Officer sold 248 shares at $4.98 ($1,235)
Page 6 of 28 · 544 filings